A Dose Escalation and Expansion Trial With BYON4228 Alone and in Combination in Patients With Advanced or Metastatic Solid Tumors
A Dose Escalation and Expansion Trial With BYON4228 Alone and in Combination in Patients With Advanced or Metastatic Solid Tumors
Active, not recruiting · NCT06932952 · Registry updated 2026-01-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Dose Escalation and Expansion Trial With BYON4228 Alone and in Combination in Patients With Advanced or Metastatic Solid Tumors | Solid Tumor | Active, not recruiting | Phase 1 | 2026-01-16 | NCT06932952 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Byondis B.V. | 3 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CIOCC Hospital Universitario HM Sanchinarro | Madrid | Spain | 1 |
| Hospital Universitario Fundación Jiménez Díaz | Madrid | Spain | 13 |
| Institut Jules Bordet | Brussels | Belgium | 23 |
| The Christie NHS Foundation Trust | Manchester | United Kingdom | 40 |
| The Royal Marsden | Sutton | United Kingdom | 2 |
| UZ Leuven | Leuven | Belgium | 82 |